HOLDEN LOWELL THOMAS (CFO) reported 2 transactions at NASCENT BIOTECH INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/4/2022ACC: 0001477932-22-002016
DirectorOfficer· CFO
+1.31M
Net shares
Net buyer
$67.0K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.31M acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.10M
Price / share
$0.05
Trade value
$55K
% of position
14.3%
—
7.67M→8.77M
Common Stock
Direct
Shares
+215K
Price / share
$0.06
Trade value
$12.04K
% of position
2.5%
—
8.77M→8.98M
Total
Net shares
+1.31M
Net value
$67.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | J · J | +1.10M | $0.05 | $55K | 14.3% | 7.67M | 8.77M |
| Common Stock Direct | — | J · J | +215K | $0.06 | $12.04K | 2.5% | 8.77M | 8.98M |
| Total | +1.31M | $67.04K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2M
Total
2M indirect2M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2M | Indirect |
| Total | 2M | 2M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported